China NMPA Product Recall - Self-expanding stent system

Boston Scientific International Medical Trading (Shanghai) Co., Ltd. initiated a voluntary Class II recall of its self-expanding stent systems, registered under CFDA (Imported) No. 20143463843. This action, published by the National Medical Products Administration (NMPA) on December 7, 2017, was prompted by an increase in complaints. The primary concern identified was the failure of these stents to fully deploy during surgical procedures, posing a potential risk to patient outcomes. The company's internal monitoring revealed this critical performance issue.

The recall specifically targets certain models, specifications, and batch numbers of the affected products. Boston Scientific is responsible for providing detailed information concerning these items, which is available in the associated "Medical Device Recall Event Report Form." The Class II designation indicates a situation where the use of or exposure to a product with issues may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote.

This regulatory action, overseen by the NMPA, underscores the importance of product safety and manufacturer accountability within the medical device industry. Companies are expected to proactively address performance issues that could impact patient safety, ensuring that medical devices function as intended throughout their use to maintain public health standards.